BR9902943A - Uma sìntese eficaz de compostos furanossulfonamida úteis para a sìntese de novos inibidores de il-1. - Google Patents

Uma sìntese eficaz de compostos furanossulfonamida úteis para a sìntese de novos inibidores de il-1.

Info

Publication number
BR9902943A
BR9902943A BR9902943-0A BR9902943A BR9902943A BR 9902943 A BR9902943 A BR 9902943A BR 9902943 A BR9902943 A BR 9902943A BR 9902943 A BR9902943 A BR 9902943A
Authority
BR
Brazil
Prior art keywords
synthesis
formula
compound
compounds useful
furanosulfonamide
Prior art date
Application number
BR9902943-0A
Other languages
English (en)
Inventor
Frank John Urban
Vytautas John Jasys
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9902943A publication Critical patent/BR9902943A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção:<B>"UMA SìNTESE EFICAZ DE COMPOSTOS FURANOSSULFONAMIDA úTEIS PARA A SìNTESE DE NOVOS INIBIDORES DE IL-1"<D>. Uma síntese eficiente de derivados de sulfonamida de fórmula incluindo a reação de um composto de fórmula II com um reagente Grignard num solvente de reação inerte, em que R' é alquila (C~ 1~-C~ 6~). O composto com a fórmula II prepara-se através da reação de um composto de fórmula III com um composto de fórmula IV em que R' é alquila (C~ 1~-C~ 6~) com um reagente de cloração e um agente de neutralização de um ácido num solvente inerte. A invenção também inclui um composto novo da fórmula em que R'é alquila (C~ 1~-C~ 6) e Q é halogênio, hidroxila ou amino.
BR9902943-0A 1998-07-27 1999-07-23 Uma sìntese eficaz de compostos furanossulfonamida úteis para a sìntese de novos inibidores de il-1. BR9902943A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9431598P 1998-07-27 1998-07-27

Publications (1)

Publication Number Publication Date
BR9902943A true BR9902943A (pt) 2000-04-18

Family

ID=22244432

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9902943-0A BR9902943A (pt) 1998-07-27 1999-07-23 Uma sìntese eficaz de compostos furanossulfonamida úteis para a sìntese de novos inibidores de il-1.

Country Status (18)

Country Link
US (1) US6022984A (pt)
EP (1) EP0976742A1 (pt)
JP (1) JP3140747B2 (pt)
KR (1) KR100323166B1 (pt)
CN (1) CN1113877C (pt)
AR (1) AR020629A1 (pt)
AU (1) AU743911B2 (pt)
BR (1) BR9902943A (pt)
CA (1) CA2278988C (pt)
HK (1) HK1024472A1 (pt)
HU (1) HUP9902530A3 (pt)
ID (1) ID23619A (pt)
IL (1) IL131002A0 (pt)
PL (1) PL334609A1 (pt)
RU (1) RU2155760C1 (pt)
TR (1) TR199901779A2 (pt)
YU (1) YU34799A (pt)
ZA (1) ZA994775B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60114902T2 (de) 2000-02-22 2006-06-01 Hitachi, Ltd. System und Verfahren zur Zylinderidentifikation in einer Brennkraftmaschine
JP2008222659A (ja) * 2007-03-14 2008-09-25 Asahi Kasei Corp スルホンアミド化合物の製造方法
MA47440B1 (fr) 2015-02-16 2021-08-31 The Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy & Undiv Sulfonylurées, composés apparentés, et leur utilisation
JP7235742B2 (ja) 2017-07-07 2023-03-08 インフレイゾーム リミテッド 新規なスルホンアミドカルボキサミド化合物
EP3668842A1 (en) 2017-08-15 2020-06-24 Inflazome Limited Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors
WO2019034693A1 (en) 2017-08-15 2019-02-21 Inflazome Limited SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3
CA3071150A1 (en) 2017-08-15 2019-02-21 Inflazome Limited Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors
WO2019092170A1 (en) 2017-11-09 2019-05-16 Inflazome Limited Novel sulfonamide carboxamide compounds
EP3759077A1 (en) 2018-03-02 2021-01-06 Inflazome Limited Novel compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477679A (en) * 1983-03-01 1984-10-16 Cpc International Inc. Production of alkyl-5-substituted-3-furoate compounds
WO1993007134A1 (de) * 1991-10-11 1993-04-15 Givaudan-Roure (International) Sa Verfahren zur herstellung von 3-s-furanderivaten
CZ293173B6 (cs) * 1997-01-29 2004-02-18 Pfizer Inc. Deriváty sulfonylmočoviny

Also Published As

Publication number Publication date
CA2278988A1 (en) 2000-01-27
HU9902530D0 (en) 1999-10-28
IL131002A0 (en) 2001-01-28
CN1244526A (zh) 2000-02-16
KR20000011978A (ko) 2000-02-25
AU743911B2 (en) 2002-02-07
JP2000044553A (ja) 2000-02-15
YU34799A (sh) 2002-11-15
PL334609A1 (en) 2000-01-31
ZA994775B (en) 2001-01-26
HK1024472A1 (en) 2000-10-13
AU4113199A (en) 2000-02-17
JP3140747B2 (ja) 2001-03-05
RU2155760C1 (ru) 2000-09-10
US6022984A (en) 2000-02-08
CA2278988C (en) 2003-04-15
HUP9902530A3 (en) 2002-04-29
TR199901779A2 (xx) 2000-02-21
AR020629A1 (es) 2002-05-22
HUP9902530A2 (hu) 2001-05-28
CN1113877C (zh) 2003-07-09
KR100323166B1 (ko) 2002-02-04
EP0976742A1 (en) 2000-02-02
ID23619A (id) 2000-05-04

Similar Documents

Publication Publication Date Title
BR9907300A (pt) Inibidores do fator xa oxoaza-heterociclila substituìdos
DK1177176T3 (da) Triarylsyrederivater som PPAR-receptorligander
ES2182234T3 (es) Inhibidores de metaloproteasa.
CY1106381T1 (el) Βιοκτονος συνθεση καθαρισμου
DE60040142D1 (de) Pyridin-imin polymerisationskatalysator
BR9913592A (pt) Compostos, processo de preparação dos compostos, e, composições farmacêuticas
BR0208105A (pt) Inibidores de metaloproteinase
ES2196527T3 (es) Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo.
NO20054787L (no) Indenderivater som farmasotiske midler
RU2008132204A (ru) Соединения для лечения метаболических заболеваний
DE60235900D1 (de) Osuppressivum
BR0206943A (pt) Inibidores de fosfodiesterase 4
TNSN02009A1 (fr) Pyrimidinones bicycliques condensees nouvelles, inhibitrices de mmp, et compositions les contenant.
BR9714787A (pt) Compostos de 4- fenilpiperidina e processo para sua preparação
CU20080213A7 (es) Nuevo procedimiento para la preparación de un intermediario útil en la preparación de imidazotriazinonas sustituidas con sulfonamida
BR9902943A (pt) Uma sìntese eficaz de compostos furanossulfonamida úteis para a sìntese de novos inibidores de il-1.
BR9810163A (pt) Compostos ou suas composições
BR0012489A (pt) Composto, composição farmacêutica, uso de um composto, e, kit para a contracepção masculina
BR9805031A (pt) Compostos de naftaleno, processo para sua preparação e composições farmacêuticas contendo os mesmos.
HUP0202881A2 (hu) Antisztatikum
AU5197599A (en) Fluorescent labelling reagents
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
BR0208753A (pt) Combinação de estabilizantes para polìmeros contendo halogênio e aplicação da mesma
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
BR0212583A (pt) Agonistas i para retinóides de alquil uréia

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.